Literature DB >> 15542631

Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication.

Hiroki Isomura1, Tatsuya Tsurumi, Mark F Stinski.   

Abstract

The human cytomegalovirus (CMV) enhancer has a distal component (positions -550 to -300) and a proximal component (-300 to -39) relative to the transcription start site (+1) of the major immediate-early (MIE) promoter. Without the distal enhancer, human CMV replicates slower and has a small-plaque phenotype. We determined the sequence requirements of the proximal enhancer by making 5'-end deletions to positions -223, -173, -116, -67, and -39. Even though recombinant virus with the proximal enhancer deleted to -39 has the minimal TATA box-containing MIE promoter element, it cannot replicate independently in human fibroblast cells. Recombinant virus with a deletion to -67 has an Sp-1 transcription factor binding site which may represent a minimal enhancer element for recombinant virus replication in human fibroblast cells. Although recombinant virus with a deletion to -223 replicates to titers at least 100-fold less than that of the wild-type virus, it replicates to titers 8-fold higher than that of recombinant virus with a deletion to -173 and 20-fold higher than that of virus with a deletion to -67. Recombinant virus with a deletion to -173 replicates more efficiently than that with a deletion to -116. There was a direct correlation between the level of infectious virus replication and time after infection, amount of MIE gene transcription, MIE and early viral protein synthesis, and viral DNA synthesis. The extent of the proximal enhancer determines the efficiency of viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542631      PMCID: PMC525030          DOI: 10.1128/JVI.78.23.12788-12799.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2.

Authors:  B Liu; T W Hermiston; M F Stinski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 2.  Immediate-early transcription regulation of human cytomegalovirus.

Authors:  T Stamminger; B Fleckenstein
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection.

Authors:  C P Chang; C L Malone; M F Stinski
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter.

Authors:  T W Hermiston; C L Malone; P R Witte; M F Stinski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site.

Authors:  M C Pizzorno; G S Hayward
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements.

Authors:  G W Hunninghake; M M Monick; B Liu; M F Stinski
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site.

Authors:  J M Cherrington; E L Khoury; E S Mocarski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter.

Authors:  Philip E Lashmit; Christopher A Lundquist; Jeffery L Meier; Mark F Stinski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.

Authors:  L C Sambucetti; J M Cherrington; G W Wilkinson; E S Mocarski
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  38 in total

1.  Tetrameric ring formation of Epstein-Barr virus polymerase processivity factor is crucial for viral replication.

Authors:  Sanae Nakayama; Takayuki Murata; Yoshihiro Yasui; Kazutaka Murayama; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.

Authors:  Montse Gustems; Eva Borst; Chris A Benedict; Carmen Pérez; Martin Messerle; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis.

Authors:  Hiroki Isomura; Mark F Stinski; Ayumi Kudoh; Sanae Nakayama; Satoko Iwahori; Yoshitaka Sato; Tatsuya Tsurumi
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

Review 4.  Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Authors:  Mark F Stinski; Hiroki Isomura
Journal:  Med Microbiol Immunol       Date:  2007-12-19       Impact factor: 3.402

5.  Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.

Authors:  Sanae Nakayama; Takayuki Murata; Kazutaka Murayama; Yoshihiro Yasui; Yoshitaka Sato; Ayumi Kudoh; Satoko Iwahori; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

6.  Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.

Authors:  Ian B DeMeritt; Jagat P Podduturi; A Michael Tilley; Maciej T Nogalski; Andrew D Yurochko
Journal:  Virology       Date:  2005-11-21       Impact factor: 3.616

7.  Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Authors:  Shinichi Saito; Takayuki Murata; Teru Kanda; Hiroki Isomura; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication.

Authors:  Hiroki Isomura; Mark F Stinski; Ayumi Kudoh; Sanae Nakayama; Takayuki Murata; Yoshitaka Sato; Satoko Iwahori; Tatsuya Tsurumi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  The human cytomegalovirus UL76 gene regulates the level of expression of the UL77 gene.

Authors:  Hiroki Isomura; Mark F Stinski; Takayuki Murata; Sanae Nakayama; Shigeki Chiba; Yoshiki Akatsuka; Teru Kanda; Tatsuya Tsurumi
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

10.  Multiple Transcripts Encode Full-Length Human Cytomegalovirus IE1 and IE2 Proteins during Lytic Infection.

Authors:  Kyle C Arend; Benjamin Ziehr; Heather A Vincent; Nathaniel J Moorman
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.